Quick Facts

Also known asNS2330
CategoryMetabolic
Half-life~9 days
Routesoral
FDA statusNot approved
StorageRoom temperature (15-25°C). Reconstituted: 90 days.

Dosing Protocols

Goal Dose Frequency Route Cycle Notes
Standard Weight Loss 500 mcg 1x/day (morning) oral 24 weeks 0.5mg oral once daily in the morning. TIPO-1 trial showed 9.2% weight reduction at this dose. Triple monoamine reuptake inhibitor (dopamine, norepinephrine, serotonin). Half-life 9.2 days.
Conservative/Starting Dose 250 mcg 1x/day (morning) oral 24 weeks 0.25mg starting dose. May increase heart rate 5-8 bpm. Morning dosing only due to insomnia risk.
Maximum Studied Dose 1 mg 1x/day oral 24 weeks 1.0mg daily was the maximum studied dose. Up to 10.6% weight loss. Contraindicated with MAOIs, SSRIs, SNRIs, and stimulants.

Protocols shown are for informational purposes only. Consult a healthcare provider before starting any peptide protocol.

Track Your Tesofensine Protocol

Log doses, manage vial inventory, set injection reminders, and visualize blood concentration levels.

Start Tracking — Free

Common Questions

What is the typical dose of Tesofensine?
A common dose for Tesofensine is 500 mcg 1x/day (morning) via oral. 0.5mg oral once daily in the morning. TIPO-1 trial showed 9.2% weight reduction at this dose. Triple monoamine reuptake inhibitor (dopamine, norepinephrine, serotonin). Half-life 9.2 days.
What is the half-life of Tesofensine?
The half-life of Tesofensine is approximately ~9 days. This determines how long the peptide remains active in your body and influences dosing frequency.
How should I store Tesofensine?
Store Tesofensine at Room temperature (15-25°C). Oral small molecule, not a peptide. Store in a cool, dry place. Available as capsules; no reconstitution needed. Controlled substance status may vary by jurisdiction. Once reconstituted, use within 90 days.
Is Tesofensine FDA approved?
Tesofensine is not FDA approved and is available for research purposes only. It has not been evaluated by the FDA for safety or efficacy in humans.

References

Related Peptides